Injections
Breast cancer
Faslo TECH
Fulvestrant Injection
Product pack shot.
A selective oestrogen receptor degrader for hormone-receptor-positive breast cancer, supplied as ready-to-inject pre-filled syringes.
250 mg / 5 mL
| Brand | Faslo TECH |
|---|---|
| Composition | Fulvestrant Injection |
| Dosage form | Solution for injection in pre-filled syringe |
| Strengths | 250 mg / 5 mL |
| Presentation | Pack of 2 pre-filled syringes |
| Therapeutic area | Breast cancer |
| Category | Prescription only (Rx) |
Product information
About Fulvestrant
- Oestrogen receptor antagonist and degrader.
- HR-positive, HER2-negative advanced or metastatic breast cancer in postmenopausal women, alone or with a CDK4/6 inhibitor.
- 500 mg dose given as two 250 mg intramuscular injections, one in each buttock.
- Store at 2–8 °C in the original carton.
Related products
